Emerald Health Therapeutics announces $18M financing and $12M secondary sale
Emerald Health Therapeutics (TSX-V: EMH) entered into a binding term sheet with a single Canadian institutional accredited investor for the sale of 3M units at $6.00 for gross proceeds of $18MRead More →